Company intelligence / Profile preview

Shard Capital

London, United Kingdom
Ownership
Private
Employees
~90
Development stage
Other
01

Overview

Shard Capital is a London-based independent investment services platform that provides asset management, wealth management, and corporate capital market services. Established in 2010, the firm operates as a multi-asset manager and broker, offering institutional-grade infrastructure to a diverse client base including private individuals and institutional investors. While not a biotechnology company itself, Shard Capital is a significant participant in the life sciences ecosystem, frequently acting as a broker or investment manager for healthcare and technology firms. The company manages various investment vehicles, such as Venture Capital Trusts (VCTs), which target high-growth opportunities in the medical, scientific, and technology sectors. Shard Capital provides essential capital raising and strategic advisory services, helping growth-stage companies navigate the complexities of public and private markets.

Industry
Investors
02

Partnerships

Arecor TherapeuticsSkinBioTherapeuticsPolarean Imaging

Beyond the preview

Go deeper on Shard Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shard Capital.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call